Kristyn Galbraith - Concepedia

Author

Kristyn Galbraith

NYU Langone Health ORCID

Also Known As

Kristyn Galbraith

Publications

483

Citations

H-Index

Concepts

All Affiliations

NYU Langone Health Memorial Sloan Kettering Cancer Center The University of Texas Southwestern Medical Center New York University Northwestern University

About

Kristyn Galbraith is an author at NYU Langone Health specializing in biostatistics, genetic epidemiology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	79
2	Public Health	1	1	79
3	Biostatistics	1	1	79
4	Pathology	1	1	79
5	Genetic Epidemiology	1	1	79

Kristyn Galbraith

Publications

224

Citations

H-Index

Page 1

	Year	Citations
Total copy number variation as a prognostic factor in adult astrocytoma subtypes Kanish Mirchia, Adwait Amod Sathe, Jamie M. Walker, Acta Neuropathologica Communications GeneticsGenetic EpidemiologyPathologyHigh-grade GliomasGlioma	2019	79
Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts Kristyn Galbraith, Kalil G. Abdullah, Jamie M. Walker, Journal of Neuropathology & Experimental Neurology	2020	62
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Neuro-Oncology Advances	2023	32
Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome Anna Kołodziejczak, Léa Guerrini‐Rousseau, Julien Masliah‐Planchon, Neuro-Oncology	2023	19
Clinical Validation of Stimulated Raman Histology for Rapid Intraoperative Diagnosis of Central Nervous System Tumors Misha Movahed-Ezazi, Mustafa Nasir-Moin, Camila Fang, Modern Pathology	2023	12
Prognostic value of DNA methylation subclassification, aneuploidy, and <i>CDKN2A/B</i> homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas Kristyn Galbraith, Mekka Garcia, Siyu Wei, Neuro-Oncology	2024	10
Dual Immune Check Point Blockade in <i>MGMT</i> -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial Andrew B. Lassman, Mei‐Yin C. Polley, Fábio M. Iwamoto, Journal of Clinical Oncology	2025	10

Page 1